ÂÜÀòÂÒÂ×

Hidehiko Otake is a seasoned executive with extensive experience in leadership roles across various sectors, including healthcare and market research. Currently serving as CEO of Corundum Systems Biology since April 2020, Hidehiko has held significant positions at Kantar, where responsibilities included Chairman, CEO, and COO of Kantar Japan, and CEO of Kantar Health from June 2011 to April 2020. Prior to this, Hidehiko was the President and CEO of Nanoegg Research Laboratories and the Founder and President of MPO, Inc. Hidehiko's earlier career includes roles at J. Walter Thompson as Executive Vice President of ThompsonConnect and as a Consultant at Bain & Company. Educational qualifications include an MBA from Harvard Business School and a Bachelor's Degree in International Relations from The University of Tokyo.